Dr. McGilvray studied medicine at McGill University, graduating in 1993. He entered the General Surgery training program at the University of Toronto that same year. During his residency, he undertook graduate studies in Dr. Ori Rotstein’s laboratory and obtained a PhD in Cell Biology. He became a Fellow of the Royal College of Physicians and Surgeons of Canada in 2001. After a clinical fellowship in Transplantation and Hepatobiliary Surgery at the Toronto General Hospital, he began his appointment at the University Health Network in 2003. He is currently an Associate Professor in the Department of Surgery at the University of Toronto.
- Diseases of the liver, particularly viral hepatitis
- Transplant immunology
- Hepatic ischemia/reperfusion injury
- Vascular reconstructive techniques for locally advanced liver and pancreas cancer
- Applicability of transplantation to oncology diagnoses
J Hepatol. 2019 Jul 04;:
Ann Hepatol. 2019 Apr 25;:
Metastatic low-grade endometrial stromal sarcoma of uterus presenting as a primary pancreatic tumor: case presentation and literature review.
Diagn Pathol. 2019 Apr 22;14(1):30
The impact of preexisting and posttransplant diabetes mellitus on outcomes following liver transplantation.
Transplantation. 2019 Apr 10;:
Cancer-related gene expression is associated with disease severity and modifiable lifestyle factors in non-alcoholic fatty liver disease.
Nutrition. 2019 Jun;62:100-107
Management and surveillance of non-functional pancreatic neuroendocrine tumours: Retrospective review.
Pancreatology. 2019 Feb 18;:
Effect of portal vein embolization on treatment plan prior to major hepatectomy for hepatocellular carcinoma.
HPB (Oxford). 2019 Feb 20;:
Live Donor Liver Transplantation for Patients with Hepatocellular Carcinoma Offers Increased Survival vs. Deceased Donation.
J Hepatol. 2019 Jan 07;:
Outcomes of Radiofrequency Ablation as First-Line Therapy for Hepatocellular Carcinoma less than 3 cm in Potentially Transplantable Patients.
J Hepatol. 2019 Jan 04;:
Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Liver Transpl. 2019 Jan;25(1):56-67
Senior Scientist, Toronto General Hospital Research Institute (TGHRI)
Associate Professor, Department of Surgery, Faculty of Medicine, University of Toronto